RAC 3.31% $1.61 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-39

  1. 443 Posts.
    lightbulb Created with Sketch. 378
    DJ fair enough you don't rate the interview. I agree it's unlikely to drive any impact on the share price.

    However it's more likely to enhance new investor awareness, potential buying and potentially resultant share price appreciation - than not doing an interview.

    I'd also argue it doesn't consume much of Dr Tillet's time. The spiel he knows back to front now and it was 4 minutes in duration. Assuming they also have direct cost... I can't imagine it's endangering the trials budgets.

    Fine if you're just venting steam, I get tired of the mind numbing, eye watering carry on about selling investment properties etc sometimes, but is there something you consider to be a more constructive use of, that, lets say, hour of management team time?

    Last edited by EDTD: 11/05/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
-0.055(3.31%)
Mkt cap ! $273.4M
Open High Low Value Volume
$1.66 $1.68 $1.61 $271.5K 166.3K

Buyers (Bids)

No. Vol. Price($)
1 1996 $1.61
 

Sellers (Offers)

Price($) Vol. No.
$1.68 1305 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.